These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 2754188

  • 1. Acute administration of pyridostigmine and clonidine has an additive stimulatory effect on GH release in normal children.
    Ghigo E, Goffi S, Mazza E, Imperiale E, Arvat E, Bellone J, Procopio M, Müller EE, Camanni F.
    J Endocrinol Invest; 1989 Feb; 12(2):99-101. PubMed ID: 2754188
    [Abstract] [Full Text] [Related]

  • 2. Comparison of growth hormone-releasing effect of growth hormone-releasing hormone, clonidine and pyridostigmine in normal children and adolescents. GH-releasing effect of GHRH, clonidine and pyridostigmine.
    Ghigo E, Arvat E, Nicolosi M, Mazza E, Camanni F.
    Panminerva Med; 1990 Feb; 32(1):1-3. PubMed ID: 2263395
    [Abstract] [Full Text] [Related]

  • 3. Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects.
    Cordido F, Dieguez C, Casanueva FF.
    J Clin Endocrinol Metab; 1990 May; 70(5):1361-70. PubMed ID: 2159483
    [Abstract] [Full Text] [Related]

  • 4. A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone.
    Ghigo E, Imperiale E, Boffano GM, Mazza E, Bellone J, Arvat E, Procopio M, Goffi S, Barreca A, Chiabotto P.
    J Endocrinol Invest; 1990 Apr; 13(4):307-16. PubMed ID: 2115060
    [Abstract] [Full Text] [Related]

  • 5. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men.
    Devesa J, Diaz MJ, Tresguerres JA, Arce V, Lima L.
    J Clin Endocrinol Metab; 1991 Aug; 73(2):251-6. PubMed ID: 1677361
    [Abstract] [Full Text] [Related]

  • 6. Acute clonidine administration potentiates spontaneous diurnal, but not nocturnal, growth hormone secretion in normal short children.
    Ghigo E, Arvat E, Nicolosi M, Bellone J, Valetto MR, Mazza E, Imperiale E, Procopio M, Ghigo MC, Camanni F.
    J Clin Endocrinol Metab; 1990 Aug; 71(2):433-5. PubMed ID: 2380338
    [Abstract] [Full Text] [Related]

  • 7. Growth hormone release during insulin tolerance, clonidine, arginine and growth hormone releasing hormone tests in short normal children and adolescents.
    Cavallo L, Acquafredda A, Liuzzi S, Russo R, Zecchino C, Leuzzi R, Giobbe T, Piacente L.
    J Endocrinol Invest; 1992 Feb; 15(2):131-5. PubMed ID: 1569289
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pyridostigmine blocks the inhibitory effect of glucocorticoids on growth hormone-releasing hormone stimulated growth hormone secretion in normal man.
    Giustina A, Girelli A, Doga M, Bodini C, Bossoni S, Romanelli G, Wehrenberg WB.
    J Clin Endocrinol Metab; 1990 Sep; 71(3):580-4. PubMed ID: 2118535
    [Abstract] [Full Text] [Related]

  • 14. The growth hormone response to pyridostigmine plus growth hormone releasing hormone is not influenced by pubertal maturation.
    Cappa M, Loche S, Salvatori R, Faedda A, Borrelli P, Cella SG, Pintor C, Müller EE.
    J Endocrinol Invest; 1991 Jan; 14(1):41-5. PubMed ID: 2045624
    [Abstract] [Full Text] [Related]

  • 15. Enhancement of cholinergic tone by pyridostigmine promotes both basal and growth hormone (GH)-releasing hormone-induced GH secretion in children of short stature.
    Ghigo E, Mazza E, Imperiale E, Rizzi G, Benso L, Müller EE, Camanni F, Massara F.
    J Clin Endocrinol Metab; 1987 Sep; 65(3):452-6. PubMed ID: 3114300
    [Abstract] [Full Text] [Related]

  • 16. Effect of the enhancement of the cholinergic tone by pyridostigmine on the exercise-induced growth hormone release in man.
    Cappa M, Grossi A, Benedetti S, Drago F, Loche S, Ghigo E.
    J Endocrinol Invest; 1993 Jun; 16(6):421-4. PubMed ID: 8370917
    [Abstract] [Full Text] [Related]

  • 17. Pyridostigmine potentiates growth hormone (GH)-releasing hormone-induced GH release in both men and women.
    Arvat E, Cappa M, Casanueva FF, Dieguez C, Ghigo E, Nicolosi M, Valcavi R, Zini M.
    J Clin Endocrinol Metab; 1993 Feb; 76(2):374-7. PubMed ID: 8432781
    [Abstract] [Full Text] [Related]

  • 18. Sexually dimorphic characteristics of clonidine-induced growth hormone release and autofeedback.
    Conway S, Moherek R, Mauceri H, Richardson L.
    Endocrinology; 1989 Nov; 125(5):2475-85. PubMed ID: 2571494
    [Abstract] [Full Text] [Related]

  • 19. Pyridostigmine-mediated growth hormone release: evidence for somatostatin involvement.
    Wehrenberg WB, Wiviott SD, Voltz DM, Giustina A.
    Endocrinology; 1992 Mar; 130(3):1445-50. PubMed ID: 1347008
    [Abstract] [Full Text] [Related]

  • 20. [Effect of pre-treatment with pyridostigmine on the stimulation of growth hormone by clonidine and GRF].
    Farello G, De Simone M, Gentile T, de Matteis F.
    Minerva Pediatr; 1991 Oct; 43(10):617-20. PubMed ID: 1758382
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.